Your Market Research Library
 

Ask For A FREE Membership Here !
 


Your Market Research starts at Allbizreport !
Order here all your market reports, company profiles, country analysis, competitive intelligence ... upon any industries and countries :
20.000 market research, 5.000 company profiles, 150 industry monitor

   
  
   
   
   Advanced Search     

   
  
   
  
   
   


Home

From Idea to Market: Product Lifecycle Management in the Pharmaceutical Industry (Market Focus)
Market Briefing, July 2007, 1516  €


Description

IntroductionThe pharmaceutical industry produces increasingly complex products, with reduced time-to-market windows, and stringent domestic and international regulatory and compliance requirements.
Datamonitor views PLM technology as one of the most rapidly growing market due to its inherent focus on time to market and product development, key business priorities in the pharmaceutical industry.ScopeIdentification and analysis of the business drivers and inhibitors that are impacting PLM adoption in the pharmaceutical industry Spending by Big Pharma and Biotech on PLM software and services in North America, Western Europe and APACHighlightsProduct lifecycle management will transform the drug development lifecycle process PLM addresses key business challenges facing the pharmaceutical industry Successful PLM for the pharmaceutical industry prevails over several constraining factorsReasons to PurchaseUnderstand and evaluate factors that will affect PLM adoption in the pharmaceutical industry Align your strategy with developments in the pharmaceutical industry Identify opportunities in an emerging market

Sommaire
 
DATAMONITOR VIEW 1
CATALYST 1
SUMMARY 1
ANALYSIS 2
Product lifecycle management will transform the drug development lifecycle process 2
The nature of a drug's lifecycle necessitates a PLM strategy 2
PLM addresses key business challenges facing the pharmaceutical industry 3
A greater focus on decreasing time to market is driving adoption of PLM 4
Harmonizing product portfolios from M&A activities sets the stage for PLM 4
Reducing the challenges and cost associated with regulatory compliance 5
The nature of the pharmaceutical drug pipeline is changing 6
Complexity of pharmaceutical products is increasing 6
The end of the Blockbuster era signifies more candidates in the pipeline 6
Successful PLM for the pharmaceutical industry prevails over several constraining factors 6
Repurposing software from other industries makes the pharmaceutical industry suspicious 6
The traditional autonomous-business-unit mentality inhibits adoption of PLM 8
PLM does not mean an antidote to new product development 8
ACTIONS 9
Articulate strategic business benefits of your PLM investment decisions 9
Take a holistic approach to PLM 9
Understand how PLM changes the lifecycle processes of a pharmaceutical product 9
APPENDIX 10
APPENDIX 10
Definitions 10
Abbreviations 10
References 10
Methodology 10
Further reading 10
Ask the analyst 11
Datamonitor consulting 11
Disclaimer 11
List of Tables
Table 1: Global PLM spending in the pharmaceutical industry by sector 2006-2012 8
List of Figures
Figure 1: The pharmaceutical product lifecycle is highly regulated, more complex and longer than other industries 3
Figure 2: Drug discovery licensing dependence of the top 10 pharmaceutical companies 5
Figure 3: Drug discovery licensing dependence of the top 10 pharmaceutical companies 7
[ Home ] [ Contact ] [ Site Map ]
© UBIQUICK SARL tous droits réservés